Clinical Trials Browser

Phase 2 × Withdrawn × In Situ Hybridization, Fluorescence × Clear all

NCT00845104 2015-03-06

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell